Answer
Patients with a high tumour burden before starting pomalidomide are at greatest risk of tumour lysis syndrome and should be monitored closely with appropriate precautions taken.
Sources for this answer
- Pomalidomide Zentiva 1mg hard capsZentiva · emc · SmPC §4.4 Special warnings and precautions for use · Version 1Document updated
Sources checked